TransAct Technologies Reports Preliminary First Quarter 2025 Financial Results
Sold Over 2,300 Terminals in the First Quarter 2025, An All-Time Quarterly High
Total FST Revenue Up
Quarterly Casino and Gaming Sales Up
"We started the year with a solid first quarter, achieving an all-time, quarterly high of 2,350 BOHA! terminal unit sales, which drove a
First Quarter 2025 Financial Highlights
-
Net Sales: Net sales for the first quarter of 2025 were
, up$13.1 million 28% sequentially and22% compared to for the first quarter of 2024 as a result of stronger sales in both FST and gaming and casino.$10.7 million -
FST Recurring Revenue: FST recurring revenue for the first quarter of 2025 was
, which represents a slight decline of$2.7 million 3% sequentially but an increase of10% compared to for the first quarter of 2024.$2.4 million -
Gross Profit: Gross profit for the first quarter of 2025 was
, resulting in gross margin of$6.4 million 48.7% , compared to gross profit of for the first quarter of 2024, resulting in a$5.6 million 52.6% gross margin. -
Operating loss: Operating loss for the first quarter of 2025 was
, compared to an operating loss of$(15) thousand for the fourth quarter of 2024 and$(1.1) million for the first quarter of 2024.$(1.3) million -
Net income (loss): Net income for the first quarter of 2025 was
, or$19 thousand per diluted share, based on 10.1 million weighted average common shares outstanding. This compares to a net loss for the first quarter of 2024 of$0.00 , or$(1.0) million per diluted share, based on 10.0 million weighted average common shares outstanding.$(0.10) -
EBITDA: EBITDA was
for the first quarter of 2025, compared to$221 thousand for the fourth quarter of 2024 and$(1.0) million for the first quarter of 2024.$(1.0) million -
Adjusted EBITDA: Adjusted EBITDA was
for the first quarter of 2025, compared to$544 thousand in the fourth quarter of 2024, and$(705) thousand for the first quarter of 2024.$(701) thousand
2025 Financial Outlook
-
Net Sales: The Company expects full year 2025 net sales of between
and$47 million .$52 million -
Adjusted EBITDA: The Company expects full year 2025 adjusted EBITDA to be between
(breakeven) and$0 .$(1.5) million
Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of these adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results.
Strategic Business Review
The Company’s Board of Directors and management have determined to suspend the Company’s strategic review process for now. Due to increasing levels of macroeconomic uncertainty and given the increased momentum in both the FST and Casino businesses, the Company intends to focus on incremental organic growth initiatives and investing in Company growth where most prudent. If and when conditions improve or opportunities arise, the Board will consider resuming the process. As always, the Board is committed to maximizing stockholder value and is constantly evaluating the best strategies to achieve that goal.
2025 First Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, May 13, 2025, beginning at 4:30 p.m. ET to discuss the Company’s preliminary first quarter 2025 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 877-704-4453 and the conference ID number is 13753569. Please call ten minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Company” followed by “Investor Relations,” then select “News & Events” followed by “Events & Presentations”), or directly here. Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measures; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income (loss) before net interest income (expense), income taxes, depreciation, and amortization. A reconciliation of EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income (loss) before net interest income (expense), income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense and (2) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation expense to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!™, AccuDate™, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 4.0 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts, and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in
©2025 TRANSACT Technologies Incorporated. All rights reserved. TransAct®, BOHA!®, AccuDate®, Epic Edge®, EPICENTRAL® and Ithaca® are registered trademarks of TransAct Technologies Incorporated.
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three months ended March 31, 2025. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three months ended March 31, 2025. During the course of the preparation of the Company’s condensed consolidated financial statements and related notes as of and for the three months ended March 31, 2025, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements included in this press release include forward-looking statements within the meaning of the
- Financial tables follow-
TRANSACT TECHNOLOGIES INCORPORATED |
|||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||
(Preliminary and Unaudited) |
|||
|
|
||
|
Three months ended
|
||
|
2025 |
|
2024 |
|
(In thousands, except per share data) |
||
|
|
|
|
Net sales |
|
|
|
Cost of sales |
6,694 |
|
5,063 |
Gross profit |
6,359 |
|
5,624 |
|
|
|
|
Operating expenses: |
|
|
|
Engineering, design and product development |
1,635 |
|
1,966 |
Selling and marketing |
2,085 |
|
2,083 |
General and administrative |
2,654 |
|
2,876 |
|
6,374 |
|
6,925 |
Operating loss |
(15) |
|
(1,301) |
|
|
|
|
Interest and other income (expense): |
|
|
|
Interest, net |
22 |
|
48 |
Other, net |
63 |
|
(60) |
|
85 |
|
(12) |
|
|
|
|
Income (loss) before income taxes |
70 |
|
(1,313) |
Income tax (expense) benefit |
(51) |
|
277 |
Net income (loss) |
|
|
|
|
|
|
|
Net income (loss) per common share: |
|
|
|
Basic |
|
|
|
Diluted |
|
|
|
|
|
|
|
Shares used in per share calculation: |
|
|
|
Basic |
10,043 |
|
9,972 |
Diluted |
10,054 |
|
9,972 |
SUPPLEMENTAL INFORMATION – SALES BY MARKET: |
|||
(Preliminary and Unaudited) |
|||
|
Three months ended
|
||
|
2025 |
|
2024 |
|
(In thousands) |
||
|
|
|
|
Food service technology |
|
|
|
POS automation |
618 |
|
651 |
Casino and gaming |
6,719 |
|
5,696 |
TransAct services group |
808 |
|
1,040 |
Total net sales |
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED |
|||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(Preliminary and Unaudited) |
|||
|
March 31, |
|
December 31, |
|
2025 |
|
2024 |
Assets: |
(In thousands) |
||
Current assets: |
|
|
|
Cash and cash equivalents |
|
|
|
Accounts receivable, net |
9,062 |
|
6,507 |
Inventories |
14,415 |
|
16,161 |
Prepaid income taxes |
402 |
|
401 |
Other current assets |
861 |
|
899 |
Total current assets |
38,918 |
|
38,362 |
|
|
|
|
Fixed assets, net |
1,645 |
|
1,818 |
Right-of-use assets, net |
905 |
|
1,141 |
Goodwill |
2,621 |
|
2,621 |
Other assets |
75 |
|
92 |
|
5,246 |
|
5,672 |
Total assets |
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity: |
|
|
|
Current liabilities: |
|
|
|
Revolving loan payable |
|
|
|
Accounts payable |
4,670 |
|
4,569 |
Accrued liabilities |
3,105 |
|
3,253 |
Lease liabilities |
852 |
|
955 |
Deferred revenue |
1,125 |
|
1,107 |
Total current liabilities |
12,752 |
|
12,884 |
|
|
|
|
Deferred revenue, net of current portion |
335 |
|
246 |
Lease liabilities, net of current portion |
96 |
|
231 |
Other liabilities |
40 |
|
40 |
|
471 |
|
517 |
Total liabilities |
13,223 |
|
13,401 |
|
|
|
|
Shareholders’ equity: |
|
|
|
Common stock |
141 |
|
141 |
Additional paid-in capital |
58,414 |
|
58,141 |
Retained earnings |
4,534 |
|
4,515 |
Accumulated other comprehensive loss, net of tax |
(38) |
|
(54) |
Treasury stock, at cost |
(32,110) |
|
(32,110) |
Total shareholders’ equity |
30,941 |
|
30,633 |
Total liabilities and shareholders’ equity |
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED |
|||
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA |
|||
NON-GAAP FINANCIAL MEASURES |
|||
(Preliminary and Unaudited) |
|||
|
|
|
|
|
Three Months Ended |
||
|
March 31, |
||
|
2025 |
|
2024 |
|
(In thousands) |
||
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
Interest income, net |
(22) |
|
(48) |
Income tax expense (benefit) |
51 |
|
(277) |
Depreciation and amortization |
173 |
|
395 |
|
|
|
|
EBITDA |
221 |
|
(966) |
|
|
|
|
Share-based compensation expense |
323 |
|
265 |
|
|
|
|
Adjusted EBITDA |
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513865712/en/
Investor Contact:
Ryan Gardella
ICR, Inc.
Ryan.Gardella@icrinc.com
Source: TransAct Technologies Incorporated